This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Infertility, Male
and you are
between 18 and 64
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

To determine the significance of systemic RANKL inhibition for male reproduction, conducting a clinical controlled randomized double blinded intervention study on infertile men, to investigating whether Denosumab (Prolia) can increase semen quality and to investigate what subgroup of infertile men that might benefit from treatment.

Provided treatments

  • Drug: Denosumab

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03030196. The sponsor of the trial is Martin Blomberg Jensen and it is looking for 95 volunteers for the current phase.
Official trial title:
Denosumab and Male Infertility: a Randomized Controlled Double-blinded Intervention Study